ERBB2 and pancreatic neoplasm: Next to that, in vitro and in vivo data in pancreatic cancer show that silencing of MUC4 expression results in altered tumor cell behavior, decreased growth, decreased ErbB2 expression and a marked reduction in metastatic incidence6,21,22.